Abstract: Background: Obesity is considered a pan-endemic health problem all over the world. Morbid obesity defined by the National Institutes of Health as a BMI of greater than or equal to 40 kg/m2 or greater than or equal to 35 kg/m2 in the presence of obesity comorbidities like hypertension, type 2 diabetes (T2D), joint pain and obstructive sleep apnea. The aim of this work was to compare between laparoscopic sleeve gastrectomy (SG) versus laparoscopic One Anastemosis gastric bypass management of T2D Obese Patients.
Methods: This prospective study was conducted on 52 people 18-65 years old of both sexes, BMI 30-50 kg/m2, with T2D, a history of failed weight loss attempts in the past and good motivation for surgery. Included patients were divided into two groups: group I (N=26): obese patients underwent Laparoscopic SG, and group II (N=26): obese patients underwent Laparoscopic Mini Gastric bypass.
Results: The mean random blood sugar after one week, 3 months, 6 months, and 1 year was statistically significant lower in bypass compared SG. The HBA1c after 3 months was remission in (69.23% and 23.08%) patients and no remission in (30.77% and 76.92%) patients between bypass and SG respectively. Thus, it was statistically significant higher in bypass compared to SG.
Conclusions: Gastric bypass was associated with better outcomes compared to SG in diabetes mellitus obese patients. This is observed in more weight loss after 1year, better HbA1c after 3, 6 months and 1 year.
